Nadia Laack, MD MS
@n_laack
Followers
1K
Following
856
Media
57
Statuses
399
Professor and Chair, Department of Radiation Oncology. @MayoRadOnc Opinions stated are my own. Like/RT ≠ endorsement
Mayo Cinic
Joined November 2013
Looking forward to connecting with our alumni at ASTRO - check your emails and register!
0
3
12
100%.
I am not aware of any better speakers on the topic of GI radiation oncology than @KrishanJethwa. Everything just becomes crystal clear. This is why you want to attend @MayoCancerCare CME courses in heme/onc. Quality updates for practitioners. @MayoHemeOnc
0
0
7
Don’t forget the Snicker Salad! Always a joy to share our slice of heaven with others.
We are so grateful to have the leadership of @n_laack who’s vegetarian and traditional Hotdish game is on point! I am very🍀to be part of this program and astounded I just celebrated 10 years at @MayoRadOnc!.
0
0
8
RT @PDBrownOnc: 25-year Cohort Study SRS sporadic meningioma.· 653 tumors SRS.· Median volume & margin dose 4.5 cc & 15 Gy.· In-field & mar….
journals.lww.com
was reviewed for patients with sporadic meningiomas who underwent SRS (Gamma Knife) as primary treatment modality from April 1997 to February 2022. Primary outcomes included progression-free survival...
0
9
0
great work Dr Routman and team @MayoRadOnc.
.@DavidRoutmanMD presented an investigator-initiated study on the use of a therapeutic vaccine alone or combined with pembrolizumab in #HPV-associated oropharyngeal carcinoma. This novel therapy is directed at HPV E6 & E7 and was delivered prior to surgery or radiation. #ASCO25
0
1
15
Thanks to Emily and team at @ASTRO_org for hosting another great chairs meeting. And thanks to all the chairs who made time to support each other on this leadership journey
3
6
32
0
2
0
For those interested in learning more about values based leadership in healthcare. Great webinars and inspiring peer and faculty interactions.
0
6
12
RT @OncLive: In the phase 3 CALGB/SWOG 80702 study, patients with ctDNA-positive stage III #ColonCancer achieved an estimated 5-year OS rat….
onclive.com
Tanios S. Bekaii-Saab, MD, details studies of ctDNA-guided strategies that are elucidating the role of adjuvant therapies in CRC and agents of promise.
0
9
0
RT @KimCorbinMD: 🥳🥳🥳 What an exciting day! Thrilled to welcome these three ⭐️⭐️⭐️ to our training program!.
0
5
0
RT @aadel_chaudhuri: We love STEM!!! And we try to give back. ☺️. Proud of my lab @MayoRadOnc @MayoClinic for organizing a STEM night at th….
0
5
0
Kauai is my favorite island to learn on….
📅 Save the date! Join @MayoRadOnc for mornings of expert-led learning and afternoons to unwind in paradise. 🌴 Explore the latest in #RadOnc and cancer treatment advances.
1
1
20
I learned so much from my colleagues- thanks to all the faculty for preparing excellent practical presentations and to @Mayo_RadCME for the best in class conference organization.
Record attendance this year at our annual Current Practice & Future Direction conference in stunning O’ahu! 🌺☀️. Thank you to @Mayo_RadCME, @KimCorbinMD & @allisongardaMD for hosting this unforgettable experience!. If you missed out this year, 👋🏼 see you in Kauai in 2026!. 🤙🏽🤙🏽
0
2
15
Thank you and may God keep you safe and bless you and the work you do everyday.
@n_laack very beautiful family , may god bless you , it was my honor to learn from you Dr Laack , happy holidays 🎄🌹.
0
0
2
Congratulations @KimCorbinMD and @MayoCancerCare. The culmination of many years of effort.
Happy to be able to report that the Alliance A221803 Mepitel Film trial is a positive trial for reducing acute radiation dermatitis in the PMRT setting! Hope this data will help improve access to film for patients! #SABCS2024
0
2
12
Thank you for your kind words - you are a talented physician and researcher and will be an incredible radiation oncologist!.
@n_laack You're our inspiration, and you're the reason I pursued radiation oncology. I believe it was the best decision I've ever made!.
1
0
10
She said yes! So excited @yazshaz ASTRO/ARRO leader and influencer extraordinaire will stay in the @MayoRadOnc family!
15
5
83
RT @KrishanJethwa: Awesome learning from my @MayoRadOnc ⭐️colleagues discussing a prospective phase 2 trial of Lutathera for meningioma and….
0
9
0